HIN
Click for more information
0.00% $2.37 heartware international, inc

J.P. Morgan's medical technology analyst holds a conference...

  1. Theman
    228 Posts.
    clock Created with Sketch.
    11/11/10
    08:15
    Post #: 7458546
    J.P. Morgan's medical technology analyst holds a conference call
    Analyst Weinstein reviews "Evaluation of the HeartWare HVAD Left Ventricular Assist Device System for the Treatment of Advanced Heart Failure: Results of the ADVANCE Bridge-to-Transplant Trial" on an Analyst/Industry conference call to be held on November 15 at 9 am hosted by J.P. Morgan. :theflyonthewall.com
    HIN Price at posting: $2.03 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add HIN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.